3Mirici A,Meral M.Comparason of the effacacy of nebulised budesonlde with parenteral corticosteroids in the treatment of acute exacerbations of chronic obstructive pulmoniry disease[J].Clin Drug Lnvest,2003,23(1):55-62.
4NHLBI/WHO workshop report:Gobal strategy for the diagnosis,Management,and prevention of chronic obstructive Pulmonary disease,2006.
6Niewoehner DE Erbland ML,Denpree RH,Collins D,et al.Effecct of systemic glucocorticoids on exacerbations of chronic obstructive pulmorutry disease[J].N Engl J Med,1999,340:1941-1947.
7Donaldson GC,Wilkinson TMA,Hurst JR,et al.Exacerbations and time spent outdoors in chronic obstructive pulmonary disease[J].Am J Respir Crit Care Med,2005,171:446-452.
8Walsh LJ,Lewis SA,Wong CA,et al.The impact of oral corticosteroid use on bonemineral density and vertebal fracture[J].Am J Resplr Crit Care Med,2002,166:691-695.
9Mehta S,Hill N S.Noinvasive ventilation[J].Am J Respir Crit Care Med,2001,163 (2):540-577.
10Pauwels R A,Buist A S,Calverley P M,et al.Global strategy for the diagnosis,management,and prevention of chronic obstructive pulmonary disease.NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary[J].Am J Respir Crit Care Med,2001,163 (5):1256-1276.
